リアルタイムPCR、デジタルPCR、エンドポイントPCRの市場規模、シェア、動向分析レポート:技術別(定量、デジタル、エンドポイント)、製品別、用途別、地域別、セグメント別予測、2024〜2030年Real-time PCR, Digital PCR, And End-point PCR Market Size, Share & Trends Analysis Report By Technology (Quantitative, Digital, End-point), By Product, By Application, By Region, And Segment Forecasts, 2024 - 2030 リアルタイムPCR、デジタルPCR、エンドポイントPCR市場の成長と動向 Grand View Research, Inc.の最新レポートによると、世界のリアルタイムPCR、デジタルPCR、エンドポイントPCR市場規模は、2024年から2030年... もっと見る
1~3営業日
サマリーリアルタイムPCR、デジタルPCR、エンドポイントPCR市場の成長と動向Grand View Research, Inc.の最新レポートによると、世界のリアルタイムPCR、デジタルPCR、エンドポイントPCR市場規模は、2024年から2030年にかけて4.2%のCAGRを記録し、2030年までに71.8億米ドルに達すると予測されている。しかし、COVID-19パンデミックの影響を除いた本当の世界リアルタイムPCR、デジタルPCR、エンドポイントPCR市場は、2023年から2030年まで年平均成長率(CAGR)8.7%で拡大すると予測されている。デジタルPCRは、類似の多数配列の存在下で少数配列を絶対定量・分析する新しい技術である。dPCRは正確で高感度な核酸測定を可能にする。加えて、リアルタイムPCRは病気の正確で早い診断と迅速で的を絞った患者ケアを提供する。 肺がん、血液がん、脳腫瘍のような疾病の増加が世界市場のアプリケーション拡大に拍車をかけている。Globocan 2020によると、肺がんはヨーロッパで2番目に多いがんで、新たに診断された症例は477,534例と推定されている。さらに、リアルタイムポリメラーゼ連鎖反応や定量ポリメラーゼ連鎖反応のような従来の技術に対するデジタルポリメラーゼ連鎖反応の利点は、予測期間を通じて採用を促進すると思われる。さらに、新興国における医療費の増加と、正確な分子疾患検出のニーズの高まりが、市場の成長を促進している。 さらに、COVID-19の大流行がデジタルPCR装置と試薬の需要を高めている。COVID-19感染は、分子診断技術として最新のデジタルPCR機器を使って検出される。WHOによると、2021年12月現在、世界中で約2億7300万人の症例が診断され、およそ530万人の死亡がCOVID-19によって記録されている。さらに製薬業界では、デジタルPCR装置は研究開発にも採用されている。 さらに、技術の進歩や世界市場における製品上市数の増加が、市場の成長を支えるものと期待されている。例えば、2021年6月、Bio-Rad Laboratories, Inc.は、COVID-19廃水スクリーニング用PREvalence ddPCR SARS-CoV-2廃水定量キットの発売を発表した。 さらに、技術の進歩のための研究開発プロジェクトの増加や、デジタルポリメラーゼ連鎖反応の開発のための企業間の協力関係の増加が、PCR検査の利用を増加させると予想される。例えば、キアゲンは2022年1月にAtila BioSystems & Actome GmbHと提携し、非侵襲的出生前検査(NIPT)技術をQIAGENのdPCRに提供することで、QIAcuityのアプリケーション数を増加させている。その結果、リアルタイムPCRおよびデジタルPCR技術の使用は予測期間中に増加すると予測される。 リアルタイムPCR、デジタルPCR、エンドポイントPCR市場レポートハイライト - 技術別では、定量PCRセグメントが2023年に83.34%を超える最大の収益シェアを占めた。これは、COVID-19のスクリーニングと診断のためのリアルタイムポリメラーゼ連鎖反応に基づく製品の導入に支えられた技術の高い採用によるものである。 - 消耗品と試薬セグメントは、より早い検出のための需要の増加とデジタルPCR消耗品と試薬を製造する重要な企業の数により、2023年に62.62%超の最大の収益シェアを占めた。 - 北米は、高い研究開発投資の存在、技術的に高度なヘルスケア研究の枠組みの利用可能性、著名なポリメラーゼ連鎖反応製造業者の強力な存在、およびこの地域における迅速診断検査の要件の拡大により、2023年に35.94%を超える収益シェアで市場を支配した。 目次Table of ContentsChapter 1 Methodology and Scope 1.1 Market Segmentation 1.1.1 Product Segment 1.1.2 Technology Segment 1.1.3 Application Segment 1.2 Regional Scope 1.3 Estimates And Forecast Timeline 1.4 Objectives 1.4.1 Objective - 1 1.4.2 Objective - 2 1.4.3 Objective - 3 1.5 Research Methodology 1.6 Information Procurement 1.6.1 Purchased Database 1.6.2 Gvr’s Internal Database 1.6.3 Secondary Sources 1.6.4 Primary Research 1.7 Information Or Data Analysis 1.7.1 Data Analysis Models 1.8 Market Formulation & Validation 1.9 Model Details 1.9.1 Commodity Flow Analysis 1.10 List of Secondary Sources 1.11 List of Abbreviations Chapter 2 Executive Summary 2.1 Market Summary 2.2 Segment Snapshot 2.3 Competitive Landscape Snapshot Chapter 3 Real-time PCR (qPCR) Market - Industry Outlook 3.1 Market Lineage Outlook 3.1.1 Parent Market Lineage Outlook 3.1.2 Related/Ancillary Market Outlook 3.2 Market Dynamics 3.2.1 Market Drivers 3.2.1.1 Rising incidence of chronic diseases, infectious diseases, and genetic disorders 3.2.1.2 Technological advancements in PCR 3.2.1.3 Implementation of MIQE guidelines 3.2.1.4 Increasing demand for rapid diagnostic tests and growing adoption of qPCR & dPCR technologies 3.2.1.5 Increasing number of CROs and forensic & research laboratories 3.2.1.6 Increasing demand for prenatal genetic testing procedures 3.2.2 Market Restraint Analysis 3.2.2.1 High device costs associated with Real time PCR (qPCR) 3.2.2.2 Stringent regulatory policies 3.3 Comparative Analysis 3.4 SWOT Analysis, By Factor (Political & Legal, Economic and Technological) 3.5 Industry Analysis - Porter’s Chapter 4 Real-time PCR (qPCR), end point PCR, and dPCR Market Analysis, Technology Scope, 2018 - 2030 (Revenue, USD Million) 4.1 Real-time PCR (qPCR), end point PCR, and dPCR Market: Technology Movement Analysis 4.2 Quantitative 4.2.1 Quantitative Market Estimates And Forecast, 2018 - 2030 (USD Million) 4.2.2 Consumables & Reagents 4.2.2.1 Consumables & Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million) 4.2.3 Instruments 4.2.3.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million) 4.2.4 Software & Services 4.2.4.1 Software & Services Market Estimates And Forecast, 2018 - 2030 (USD Million) 4.3 Digital 4.3.1 Digital Market Estimates And Forecast, 2018 - 2030 (USD Million) 4.3.2 Consumables & Reagents 4.3.2.1 Consumables & Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million) 4.3.3 Instruments 4.3.3.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million) 4.3.4 Software & Services 4.3.4.1 Software & Services Market Estimates And Forecast, 2018 - 2030 (USD Million) 4.4 End-Point Pcr 4.4.1 End-Point Pcr Market Estimates And Forecast, 2018 - 2030 (USD Million) 4.4.2 Consumables & Reagents 4.4.2.1 Consumables & Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million) 4.4.3 Instruments 4.4.3.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million) 4.4.4 Software & Services 4.4.4.1 Software & services market estimates and forecast, 2018 - 2030 (USD Million) Chapter 5 Real-time PCR (qPCR), end point PCR, and dPCR Market Analysis, Product Scope, 2018 - 2030 (Revenue, USD Million) 5.1 Real-time PCR (qPCR), end point PCR, and dPCR Market: Products Movement Analysis 5.2 Consumables & Reagents 5.2.1 Consumables & Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million) 5.3 Instruments 5.3.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million) 5.4 Software & Services 5.4.1 Software & Services Market Estimates And Forecast, 2018 - 2030 (USD Million) Chapter 6 Real-time PCR (qPCR), end point PCR, and dPCR Market Analysis, Application Scope, 2018 - 2030 (Revenue, USD Million) 6.1 Real-time PCR (qPCR), end point PCR, and dPCR Market: Application Movement Analysis 6.2 Clinical 6.2.1 Clinical Market Estimates And Forecast, 2018 - 2030 (USD Million) 6.2.2 Pathogen Testing 6.2.2.1 Pathogen Testing Market Estimates And Forecast, 2018 - 2030 (USD Million) 6.2.3 Oncology Testing 6.2.3.1 Oncology Testing Market Estimates And Forecast, 2018 - 2030 (USD Million) 6.2.4 Blood Screening 6.2.4.1 Blood Screening Market Estimates And Forecast, 2018 - 2030 (USD Million) 6.2.5 Liquid Biopsy Testing 6.2.5.1 Liquid Biopsy Testing Market Estimates And Forecast, 2018 - 2030 (USD Million) 6.2.6 Dpcr-Based Non-Invasive Prenatal Testing (Nipt) 6.2.6.1 Dpcr-Based Non-Invasive Prenatal Testing (Nipt) Market Estimates And Forecast, 2018 - 2030 (USD Million) 6.2.7 Others 6.2.7.1 Others Market Estimates And Forecast, 2018 - 2030 (USD Million) 6.3 Research 6.3.1 Research Market Estimates And Forecast, 2018 - 2030 (USD Million) 6.3.2 Stem Cell Research 6.3.2.1 Stem Cell Research Market Estimates And Forecast, 2018 - 2030 (USD Million) 6.3.3 Dna Cloning & Sequencing 6.3.3.1 Dna Cloning & Sequencing Market Estimates And Forecast, 2018 - 2030 (USD Million) 6.3.4 Recombinant Dna Technology 6.3.4.1 Recombinant Dna Technology Market Estimates And Forecast, 2018 - 2030 (USD Million) 6.3.5 Rare Mutation Detection 6.3.5.1 Rare Mutation Detection Market Estimates And Forecast, 2018 - 2030 (USD Million) 6.3.6 Gene Expression 6.3.6.1 Gene Expression Market Estimates And Forecast, 2018 - 2030 (USD Million) 6.3.7 Single-Cell Analysis 6.3.7.1 Single-Cell Analysis Market Estimates And Forecast, 2018 - 2030 (USD Million) 6.3.8 Microbiome Analysis 6.3.8.1 Microbiome Analysis Market Estimates And Forecast, 2018 - 2030 (USD Million) 6.3.9 Copy Number Variation Analysis 6.3.9.1 Copy Number Variation Analysis Market Estimates And Forecast, 2018 - 2030 (USD Million) 6.3.10 Library Quantification (Ngs) 6.3.10.1 Library Quantification (Ngs) Market Estimates And Forecast, 2018 - 2030 (USD Million) 6.3.11 Characterization Of Low-Fold Changes In Mrna And Mirna Expression 6.3.11.1 Characterization Of Low-Fold Changes In Mrna And Mirna Expression Market Estimates And Forecast, 2018 - 2030 (USD Million) 6.3.12 Species Identification 6.3.12.1 Species identification market estimates and forecast, 2018 - 2030 (USD Million) 6.3.13 GMO Detection 6.3.13.1 GMO detection market estimates and forecast, 2018 - 2030 (USD Million) 6.4 Forensics and Others 6.4.1.1 Forensics and others market estimates and forecast, 2018 - 2030 (USD Million) Chapter 7 Real-time PCR (qPCR), end point PCR, and dPCR Market Analysis, Regional Scope, 2018 - 2030 (Revenue, USD Million) 7.1 Market Share Analysis by Country, 2023 & 2030 7.1.1 North America 7.1.1.1 North America market estimates and forecast, 2018 - 2030 (USD Million) 7.1.1.2 U.S. 7.1.1.2.1 U.S. market estimates and forecast, 2018 - 2030 (USD Million) 7.1.1.2.2 Key country dynamics 7.1.1.2.3 Competitive scenario 7.1.1.2.4 Regulatory framework 7.1.1.3 Canada 7.1.1.3.1 Canada market estimates and forecast, 2018 - 2030 (USD Million) 7.1.1.3.2 Key country dynamics 7.1.1.3.3 Competitive scenario 7.1.1.3.4 Regulatory framework 7.1.2 Europe 7.1.2.1 Europe market estimates and forecast, 2018 - 2030 (USD Million) 7.1.2.2 UK 7.1.2.2.1 UK market estimates and forecast, 2018 - 2030 (USD Million) 7.1.2.2.2 Key country dynamics 7.1.2.2.3 Competitive scenario 7.1.2.2.4 Regulatory framework 7.1.2.3 Germany 7.1.2.3.1 Germany market estimates and forecast, 2018 - 2030 (USD Million) 7.1.2.3.2 Key country dynamics 7.1.2.3.3 Competitive scenario 7.1.2.3.4 Regulatory framework 7.1.2.4 France 7.1.2.4.1 France market estimates and forecast, 2018 - 2030 (USD Million) 7.1.2.4.2 Key country dynamics 7.1.2.4.3 Competitive scenario 7.1.2.4.4 Regulatory framework 7.1.2.5 Italy 7.1.2.5.1 Italy market estimates and forecast, 2018 - 2030 (USD Million) 7.1.2.5.2 Key country dynamics 7.1.2.5.3 Competitive scenario 7.1.2.5.4 Regulatory framework 7.1.2.6 Spain 7.1.2.6.1 Spain market estimates and forecast, 2018 - 2030 (USD Million) 7.1.2.6.2 Key country dynamics 7.1.2.6.3 Competitive scenario 7.1.2.6.4 Regulatory framework 7.1.2.7 Denmark 7.1.2.7.1 Denmark market estimates and forecast, 2018 - 2030 (USD Million) 7.1.2.7.2 Key country dynamics 7.1.2.7.3 Competitive scenario 7.1.2.7.4 Regulatory framework 7.1.2.8 Sweden 7.1.2.8.1 Sweden market estimates and forecast, 2018 - 2030 (USD Million) 7.1.2.8.2 Key country dynamics 7.1.2.8.3 Competitive scenario 7.1.2.8.4 Regulatory framework 7.1.2.9 Norway 7.1.2.9.1 Norway market estimates and forecast, 2018 - 2030 (USD Million) 7.1.2.9.2 Key country dynamics 7.1.2.9.3 Competitive scenario 7.1.2.9.4 Regulatory framework 7.1.3 Asia-Pacific 7.1.3.1 Asia-Pacific market estimates and forecast, 2018 - 2030 (USD Million) 7.1.3.2 Japan 7.1.3.2.1 Japan market estimates and forecast, 2018 - 2030 (USD Million) 7.1.3.2.2 Key country dynamics 7.1.3.2.3 Competitive scenario 7.1.3.2.4 Regulatory framework 7.1.3.3 India 7.1.3.3.1 India market estimates and forecast, 2018 - 2030 (USD Million) 7.1.3.3.2 Key country dynamics 7.1.3.3.3 Competitive scenario 7.1.3.3.4 Regulatory framework 7.1.3.4 Australia 7.1.3.4.1 Australia market estimates and forecast, 2018 - 2030 (USD Million) 7.1.3.4.2 Key country dynamics 7.1.3.4.3 Competitive scenario 7.1.3.4.4 Regulatory framework 7.1.3.5 China 7.1.3.5.1 China market estimates and forecast, 2018 - 2030 (USD Million) 7.1.3.5.2 Key country dynamics 7.1.3.5.3 Competitive scenario 7.1.3.5.4 Regulatory framework 7.1.3.6 South Korea 7.1.3.6.1 South Korea market estimates and forecast, 2018 - 2030 (USD Million) 7.1.3.6.2 Key country dynamics 7.1.3.6.3 Competitive scenario 7.1.3.6.4 Regulatory framework 7.1.3.7 Thailand 7.1.3.7.1 Thailand market estimates and forecast, 2018 - 2030 (USD Million) 7.1.3.7.2 Key country dynamics 7.1.3.7.3 Competitive scenario 7.1.3.7.4 Regulatory framework 7.1.4 Latin America 7.1.4.1 Latin America market estimates and forecast, 2018 - 2030 (USD Million) 7.1.4.2 Brazil 7.1.4.2.1 Brazil market estimates and forecast, 2018 - 2030 (USD Million) 7.1.4.2.2 Key country dynamics 7.1.4.2.3 Competitive scenario 7.1.4.2.4 Regulatory framework 7.1.4.3 Mexico 7.1.4.3.1 Mexico market estimates and forecast, 2018 - 2030 (USD Million) 7.1.4.3.2 Key country dynamics 7.1.4.3.3 Competitive scenario 7.1.4.3.4 Regulatory framework 7.1.4.4 Argentina 7.1.4.4.1 Argentina market estimates and forecast, 2018 - 2030 (USD Million) 7.1.4.4.2 Key country dynamics 7.1.4.4.3 Competitive scenario 7.1.4.4.4 Regulatory framework 7.1.5 Middle East & Africa 7.1.5.1 Middle East & Africa market estimates and forecast, 2018 - 2030 (USD Million) 7.1.5.2 South Africa 7.1.5.2.1 South Africa market estimates and forecast, 2018 - 2030 (USD Million) 7.1.5.2.2 Key country dynamics 7.1.5.2.3 Competitive scenario 7.1.5.2.4 Regulatory framework 7.1.5.3 Saudi Arabia 7.1.5.3.1 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million) 7.1.5.3.2 Key country dynamics 7.1.5.3.3 Competitive scenario 7.1.5.3.4 Regulatory framework 7.1.5.4 UAE 7.1.5.4.1 UAE market estimates and forecast, 2018 - 2030 (USD Million) 7.1.5.4.2 Key country dynamics 7.1.5.4.3 Competitive scenario 7.1.5.4.4 Regulatory framework 7.1.5.5 Kuwait 7.1.5.5.1 Kuwait market estimates and forecast, 2018 - 2030 (USD Million) 7.1.5.5.2 Key country dynamics 7.1.5.5.3 Competitive scenario 7.1.5.5.4 Regulatory framework Chapter 8 Real-time PCR (qPCR), end point PCR, and dPCR Market - Competitive Landscape 8.1 Company Categorization 8.2 Strategy Mapping 8.2.1 New Product Launch 8.2.2 Partnerships 8.2.3 Acquisition 8.2.4 Collaboration 8.2.5 Funding 8.3 Key Company Market Share Analysis, 2023 8.4 Company Profiles 8.4.1 Abbott 8.4.1.1 Company Overview 8.4.1.2 Financial Performance 8.4.1.3 Product Benchmarking 8.4.1.4 Strategic Initiatives 8.4.2 Qiagen 8.4.2.1 Company Overview 8.4.2.2 Financial Performance 8.4.2.3 Product Benchmarking 8.4.2.4 Strategic Initiatives 8.4.3 Bio-Rad Laboratories, Inc. 8.4.3.1 Company Overview 8.4.3.2 Financial Performance 8.4.3.3 Product Benchmarking 8.4.3.4 Strategic Initiatives 8.4.4 Agilent Technologies, Inc. 8.4.4.1 Company Overview 8.4.4.2 Financial Performance 8.4.4.3 Product Benchmarking 8.4.4.4 Strategic Initiatives 8.4.5 Thermo Fisher Scientific, Inc. 8.4.5.1 Company Overview 8.4.5.2 Affymetrix 8.4.5.3 Company Overview 8.4.5.4 Financial Performance 8.4.5.5 Product Benchmarking 8.4.5.6 Strategic Initiatives 8.4.6 Ge Healthcare 8.4.6.1 Company Overview 8.4.6.2 Financial Performance 8.4.6.3 Product Benchmarking 8.4.6.4 Strategic Initiatives 8.4.7 Biomérieux Sa 8.4.7.1 Company Overview 8.4.7.2 Financial Performance 8.4.7.3 Product Benchmarking 8.4.7.4 Strategic Initiatives 8.4.8 F. Hoffmann-La Roche Ltd 8.4.8.1 Company Overview 8.4.8.2 Financial Performance 8.4.8.3 Product Benchmarking 8.4.8.4 Strategic Initiatives 8.4.9 Fluidigm Corporation 8.4.9.1 Company Overview 8.4.9.2 Financial Performance 8.4.9.3 Product Benchmarking 8.4.9.4 Strategic Initiatives
SummaryReal-time PCR, Digital PCR, And End-point PCR Market Growth & Trends Table of ContentsTable of ContentsChapter 1 Methodology and Scope 1.1 Market Segmentation 1.1.1 Product Segment 1.1.2 Technology Segment 1.1.3 Application Segment 1.2 Regional Scope 1.3 Estimates And Forecast Timeline 1.4 Objectives 1.4.1 Objective - 1 1.4.2 Objective - 2 1.4.3 Objective - 3 1.5 Research Methodology 1.6 Information Procurement 1.6.1 Purchased Database 1.6.2 Gvr’s Internal Database 1.6.3 Secondary Sources 1.6.4 Primary Research 1.7 Information Or Data Analysis 1.7.1 Data Analysis Models 1.8 Market Formulation & Validation 1.9 Model Details 1.9.1 Commodity Flow Analysis 1.10 List of Secondary Sources 1.11 List of Abbreviations Chapter 2 Executive Summary 2.1 Market Summary 2.2 Segment Snapshot 2.3 Competitive Landscape Snapshot Chapter 3 Real-time PCR (qPCR) Market - Industry Outlook 3.1 Market Lineage Outlook 3.1.1 Parent Market Lineage Outlook 3.1.2 Related/Ancillary Market Outlook 3.2 Market Dynamics 3.2.1 Market Drivers 3.2.1.1 Rising incidence of chronic diseases, infectious diseases, and genetic disorders 3.2.1.2 Technological advancements in PCR 3.2.1.3 Implementation of MIQE guidelines 3.2.1.4 Increasing demand for rapid diagnostic tests and growing adoption of qPCR & dPCR technologies 3.2.1.5 Increasing number of CROs and forensic & research laboratories 3.2.1.6 Increasing demand for prenatal genetic testing procedures 3.2.2 Market Restraint Analysis 3.2.2.1 High device costs associated with Real time PCR (qPCR) 3.2.2.2 Stringent regulatory policies 3.3 Comparative Analysis 3.4 SWOT Analysis, By Factor (Political & Legal, Economic and Technological) 3.5 Industry Analysis - Porter’s Chapter 4 Real-time PCR (qPCR), end point PCR, and dPCR Market Analysis, Technology Scope, 2018 - 2030 (Revenue, USD Million) 4.1 Real-time PCR (qPCR), end point PCR, and dPCR Market: Technology Movement Analysis 4.2 Quantitative 4.2.1 Quantitative Market Estimates And Forecast, 2018 - 2030 (USD Million) 4.2.2 Consumables & Reagents 4.2.2.1 Consumables & Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million) 4.2.3 Instruments 4.2.3.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million) 4.2.4 Software & Services 4.2.4.1 Software & Services Market Estimates And Forecast, 2018 - 2030 (USD Million) 4.3 Digital 4.3.1 Digital Market Estimates And Forecast, 2018 - 2030 (USD Million) 4.3.2 Consumables & Reagents 4.3.2.1 Consumables & Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million) 4.3.3 Instruments 4.3.3.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million) 4.3.4 Software & Services 4.3.4.1 Software & Services Market Estimates And Forecast, 2018 - 2030 (USD Million) 4.4 End-Point Pcr 4.4.1 End-Point Pcr Market Estimates And Forecast, 2018 - 2030 (USD Million) 4.4.2 Consumables & Reagents 4.4.2.1 Consumables & Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million) 4.4.3 Instruments 4.4.3.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million) 4.4.4 Software & Services 4.4.4.1 Software & services market estimates and forecast, 2018 - 2030 (USD Million) Chapter 5 Real-time PCR (qPCR), end point PCR, and dPCR Market Analysis, Product Scope, 2018 - 2030 (Revenue, USD Million) 5.1 Real-time PCR (qPCR), end point PCR, and dPCR Market: Products Movement Analysis 5.2 Consumables & Reagents 5.2.1 Consumables & Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million) 5.3 Instruments 5.3.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million) 5.4 Software & Services 5.4.1 Software & Services Market Estimates And Forecast, 2018 - 2030 (USD Million) Chapter 6 Real-time PCR (qPCR), end point PCR, and dPCR Market Analysis, Application Scope, 2018 - 2030 (Revenue, USD Million) 6.1 Real-time PCR (qPCR), end point PCR, and dPCR Market: Application Movement Analysis 6.2 Clinical 6.2.1 Clinical Market Estimates And Forecast, 2018 - 2030 (USD Million) 6.2.2 Pathogen Testing 6.2.2.1 Pathogen Testing Market Estimates And Forecast, 2018 - 2030 (USD Million) 6.2.3 Oncology Testing 6.2.3.1 Oncology Testing Market Estimates And Forecast, 2018 - 2030 (USD Million) 6.2.4 Blood Screening 6.2.4.1 Blood Screening Market Estimates And Forecast, 2018 - 2030 (USD Million) 6.2.5 Liquid Biopsy Testing 6.2.5.1 Liquid Biopsy Testing Market Estimates And Forecast, 2018 - 2030 (USD Million) 6.2.6 Dpcr-Based Non-Invasive Prenatal Testing (Nipt) 6.2.6.1 Dpcr-Based Non-Invasive Prenatal Testing (Nipt) Market Estimates And Forecast, 2018 - 2030 (USD Million) 6.2.7 Others 6.2.7.1 Others Market Estimates And Forecast, 2018 - 2030 (USD Million) 6.3 Research 6.3.1 Research Market Estimates And Forecast, 2018 - 2030 (USD Million) 6.3.2 Stem Cell Research 6.3.2.1 Stem Cell Research Market Estimates And Forecast, 2018 - 2030 (USD Million) 6.3.3 Dna Cloning & Sequencing 6.3.3.1 Dna Cloning & Sequencing Market Estimates And Forecast, 2018 - 2030 (USD Million) 6.3.4 Recombinant Dna Technology 6.3.4.1 Recombinant Dna Technology Market Estimates And Forecast, 2018 - 2030 (USD Million) 6.3.5 Rare Mutation Detection 6.3.5.1 Rare Mutation Detection Market Estimates And Forecast, 2018 - 2030 (USD Million) 6.3.6 Gene Expression 6.3.6.1 Gene Expression Market Estimates And Forecast, 2018 - 2030 (USD Million) 6.3.7 Single-Cell Analysis 6.3.7.1 Single-Cell Analysis Market Estimates And Forecast, 2018 - 2030 (USD Million) 6.3.8 Microbiome Analysis 6.3.8.1 Microbiome Analysis Market Estimates And Forecast, 2018 - 2030 (USD Million) 6.3.9 Copy Number Variation Analysis 6.3.9.1 Copy Number Variation Analysis Market Estimates And Forecast, 2018 - 2030 (USD Million) 6.3.10 Library Quantification (Ngs) 6.3.10.1 Library Quantification (Ngs) Market Estimates And Forecast, 2018 - 2030 (USD Million) 6.3.11 Characterization Of Low-Fold Changes In Mrna And Mirna Expression 6.3.11.1 Characterization Of Low-Fold Changes In Mrna And Mirna Expression Market Estimates And Forecast, 2018 - 2030 (USD Million) 6.3.12 Species Identification 6.3.12.1 Species identification market estimates and forecast, 2018 - 2030 (USD Million) 6.3.13 GMO Detection 6.3.13.1 GMO detection market estimates and forecast, 2018 - 2030 (USD Million) 6.4 Forensics and Others 6.4.1.1 Forensics and others market estimates and forecast, 2018 - 2030 (USD Million) Chapter 7 Real-time PCR (qPCR), end point PCR, and dPCR Market Analysis, Regional Scope, 2018 - 2030 (Revenue, USD Million) 7.1 Market Share Analysis by Country, 2023 & 2030 7.1.1 North America 7.1.1.1 North America market estimates and forecast, 2018 - 2030 (USD Million) 7.1.1.2 U.S. 7.1.1.2.1 U.S. market estimates and forecast, 2018 - 2030 (USD Million) 7.1.1.2.2 Key country dynamics 7.1.1.2.3 Competitive scenario 7.1.1.2.4 Regulatory framework 7.1.1.3 Canada 7.1.1.3.1 Canada market estimates and forecast, 2018 - 2030 (USD Million) 7.1.1.3.2 Key country dynamics 7.1.1.3.3 Competitive scenario 7.1.1.3.4 Regulatory framework 7.1.2 Europe 7.1.2.1 Europe market estimates and forecast, 2018 - 2030 (USD Million) 7.1.2.2 UK 7.1.2.2.1 UK market estimates and forecast, 2018 - 2030 (USD Million) 7.1.2.2.2 Key country dynamics 7.1.2.2.3 Competitive scenario 7.1.2.2.4 Regulatory framework 7.1.2.3 Germany 7.1.2.3.1 Germany market estimates and forecast, 2018 - 2030 (USD Million) 7.1.2.3.2 Key country dynamics 7.1.2.3.3 Competitive scenario 7.1.2.3.4 Regulatory framework 7.1.2.4 France 7.1.2.4.1 France market estimates and forecast, 2018 - 2030 (USD Million) 7.1.2.4.2 Key country dynamics 7.1.2.4.3 Competitive scenario 7.1.2.4.4 Regulatory framework 7.1.2.5 Italy 7.1.2.5.1 Italy market estimates and forecast, 2018 - 2030 (USD Million) 7.1.2.5.2 Key country dynamics 7.1.2.5.3 Competitive scenario 7.1.2.5.4 Regulatory framework 7.1.2.6 Spain 7.1.2.6.1 Spain market estimates and forecast, 2018 - 2030 (USD Million) 7.1.2.6.2 Key country dynamics 7.1.2.6.3 Competitive scenario 7.1.2.6.4 Regulatory framework 7.1.2.7 Denmark 7.1.2.7.1 Denmark market estimates and forecast, 2018 - 2030 (USD Million) 7.1.2.7.2 Key country dynamics 7.1.2.7.3 Competitive scenario 7.1.2.7.4 Regulatory framework 7.1.2.8 Sweden 7.1.2.8.1 Sweden market estimates and forecast, 2018 - 2030 (USD Million) 7.1.2.8.2 Key country dynamics 7.1.2.8.3 Competitive scenario 7.1.2.8.4 Regulatory framework 7.1.2.9 Norway 7.1.2.9.1 Norway market estimates and forecast, 2018 - 2030 (USD Million) 7.1.2.9.2 Key country dynamics 7.1.2.9.3 Competitive scenario 7.1.2.9.4 Regulatory framework 7.1.3 Asia-Pacific 7.1.3.1 Asia-Pacific market estimates and forecast, 2018 - 2030 (USD Million) 7.1.3.2 Japan 7.1.3.2.1 Japan market estimates and forecast, 2018 - 2030 (USD Million) 7.1.3.2.2 Key country dynamics 7.1.3.2.3 Competitive scenario 7.1.3.2.4 Regulatory framework 7.1.3.3 India 7.1.3.3.1 India market estimates and forecast, 2018 - 2030 (USD Million) 7.1.3.3.2 Key country dynamics 7.1.3.3.3 Competitive scenario 7.1.3.3.4 Regulatory framework 7.1.3.4 Australia 7.1.3.4.1 Australia market estimates and forecast, 2018 - 2030 (USD Million) 7.1.3.4.2 Key country dynamics 7.1.3.4.3 Competitive scenario 7.1.3.4.4 Regulatory framework 7.1.3.5 China 7.1.3.5.1 China market estimates and forecast, 2018 - 2030 (USD Million) 7.1.3.5.2 Key country dynamics 7.1.3.5.3 Competitive scenario 7.1.3.5.4 Regulatory framework 7.1.3.6 South Korea 7.1.3.6.1 South Korea market estimates and forecast, 2018 - 2030 (USD Million) 7.1.3.6.2 Key country dynamics 7.1.3.6.3 Competitive scenario 7.1.3.6.4 Regulatory framework 7.1.3.7 Thailand 7.1.3.7.1 Thailand market estimates and forecast, 2018 - 2030 (USD Million) 7.1.3.7.2 Key country dynamics 7.1.3.7.3 Competitive scenario 7.1.3.7.4 Regulatory framework 7.1.4 Latin America 7.1.4.1 Latin America market estimates and forecast, 2018 - 2030 (USD Million) 7.1.4.2 Brazil 7.1.4.2.1 Brazil market estimates and forecast, 2018 - 2030 (USD Million) 7.1.4.2.2 Key country dynamics 7.1.4.2.3 Competitive scenario 7.1.4.2.4 Regulatory framework 7.1.4.3 Mexico 7.1.4.3.1 Mexico market estimates and forecast, 2018 - 2030 (USD Million) 7.1.4.3.2 Key country dynamics 7.1.4.3.3 Competitive scenario 7.1.4.3.4 Regulatory framework 7.1.4.4 Argentina 7.1.4.4.1 Argentina market estimates and forecast, 2018 - 2030 (USD Million) 7.1.4.4.2 Key country dynamics 7.1.4.4.3 Competitive scenario 7.1.4.4.4 Regulatory framework 7.1.5 Middle East & Africa 7.1.5.1 Middle East & Africa market estimates and forecast, 2018 - 2030 (USD Million) 7.1.5.2 South Africa 7.1.5.2.1 South Africa market estimates and forecast, 2018 - 2030 (USD Million) 7.1.5.2.2 Key country dynamics 7.1.5.2.3 Competitive scenario 7.1.5.2.4 Regulatory framework 7.1.5.3 Saudi Arabia 7.1.5.3.1 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million) 7.1.5.3.2 Key country dynamics 7.1.5.3.3 Competitive scenario 7.1.5.3.4 Regulatory framework 7.1.5.4 UAE 7.1.5.4.1 UAE market estimates and forecast, 2018 - 2030 (USD Million) 7.1.5.4.2 Key country dynamics 7.1.5.4.3 Competitive scenario 7.1.5.4.4 Regulatory framework 7.1.5.5 Kuwait 7.1.5.5.1 Kuwait market estimates and forecast, 2018 - 2030 (USD Million) 7.1.5.5.2 Key country dynamics 7.1.5.5.3 Competitive scenario 7.1.5.5.4 Regulatory framework Chapter 8 Real-time PCR (qPCR), end point PCR, and dPCR Market - Competitive Landscape 8.1 Company Categorization 8.2 Strategy Mapping 8.2.1 New Product Launch 8.2.2 Partnerships 8.2.3 Acquisition 8.2.4 Collaboration 8.2.5 Funding 8.3 Key Company Market Share Analysis, 2023 8.4 Company Profiles 8.4.1 Abbott 8.4.1.1 Company Overview 8.4.1.2 Financial Performance 8.4.1.3 Product Benchmarking 8.4.1.4 Strategic Initiatives 8.4.2 Qiagen 8.4.2.1 Company Overview 8.4.2.2 Financial Performance 8.4.2.3 Product Benchmarking 8.4.2.4 Strategic Initiatives 8.4.3 Bio-Rad Laboratories, Inc. 8.4.3.1 Company Overview 8.4.3.2 Financial Performance 8.4.3.3 Product Benchmarking 8.4.3.4 Strategic Initiatives 8.4.4 Agilent Technologies, Inc. 8.4.4.1 Company Overview 8.4.4.2 Financial Performance 8.4.4.3 Product Benchmarking 8.4.4.4 Strategic Initiatives 8.4.5 Thermo Fisher Scientific, Inc. 8.4.5.1 Company Overview 8.4.5.2 Affymetrix 8.4.5.3 Company Overview 8.4.5.4 Financial Performance 8.4.5.5 Product Benchmarking 8.4.5.6 Strategic Initiatives 8.4.6 Ge Healthcare 8.4.6.1 Company Overview 8.4.6.2 Financial Performance 8.4.6.3 Product Benchmarking 8.4.6.4 Strategic Initiatives 8.4.7 Biomérieux Sa 8.4.7.1 Company Overview 8.4.7.2 Financial Performance 8.4.7.3 Product Benchmarking 8.4.7.4 Strategic Initiatives 8.4.8 F. Hoffmann-La Roche Ltd 8.4.8.1 Company Overview 8.4.8.2 Financial Performance 8.4.8.3 Product Benchmarking 8.4.8.4 Strategic Initiatives 8.4.9 Fluidigm Corporation 8.4.9.1 Company Overview 8.4.9.2 Financial Performance 8.4.9.3 Product Benchmarking 8.4.9.4 Strategic Initiatives
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(医療)の最新刊レポート
Grand View Research社の臨床検査分野での最新刊レポート
本レポートと同じKEY WORD(pcr)の最新刊レポート
よくあるご質問Grand View Research社はどのような調査会社ですか?グランドビューリサーチ(Grand View Research)は通信技術、化学品、材料、ヘルスケア、エネルギーなど広範な市場を対象にした調査報告書を出版しています。 もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/11/14 10:27 156.77 円 166.04 円 201.95 円 |